Hexagon Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
14,135
+3,554
| +34% | +$281K | 0.25% | 40 |
|
|
2025
Q1 | $950K | Buy |
10,581
+4,090
| +63% | +$367K | 0.18% | 60 |
|
|
2024
Q4 | $646K | Buy |
6,491
+1,148
| +21% | +$114K | 0.12% | 82 |
|
|
2024
Q3 | $607K | Sell |
5,343
-170
| -3% | -$19.3K | 0.12% | 82 |
|
|
2024
Q2 | $682K | Buy |
5,513
+375
| +7% | +$46.4K | 0.15% | 74 |
|
|
2024
Q1 | $678K | Sell |
5,138
-566
| -10% | -$74.7K | 0.15% | 70 |
|
|
2023
Q4 | $622K | Buy |
5,704
+2,108
| +59% | +$230K | 0.15% | 73 |
|
|
2023
Q3 | $370K | Sell |
3,596
-406
| -10% | -$41.8K | 0.1% | 104 |
|
|
2023
Q2 | $462K | Sell |
4,002
-170
| -4% | -$19.6K | 0.12% | 86 |
|
|
2023
Q1 | $444K | Sell |
4,172
-972
| -19% | -$103K | 0.12% | 87 |
|
|
2022
Q4 | $571K | Sell |
5,144
-3,536
| -41% | -$392K | 0.17% | 65 |
|
|
2022
Q3 | $747K | Buy |
8,680
+2,593
| +43% | +$223K | 0.22% | 49 |
|
|
2022
Q2 | $555K | Buy |
6,087
+982
| +19% | +$89.5K | 0.17% | 73 |
|
|
2022
Q1 | $419K | Buy |
5,105
+261
| +5% | +$21.4K | 0.11% | 109 |
|
|
2021
Q4 | $371K | Buy |
4,844
+335
| +7% | +$25.7K | 0.1% | 119 |
|
|
2021
Q3 | $339K | Sell |
4,509
-819
| -15% | -$61.6K | 0.1% | 111 |
|
|
2021
Q2 | $414K | Buy |
5,328
+1,165
| +28% | +$90.5K | 0.11% | 94 |
|
|
2021
Q1 | $306K | Sell |
4,163
-34
| -0.8% | -$2.5K | 0.08% | 109 |
|
|
2020
Q4 | $327K | Buy |
4,197
+14
| +0.3% | +$1.09K | 0.1% | 87 |
|
|
2020
Q3 | $306K | Buy |
+4,183
| New | +$306K | 0.1% | 91 |
|